Vishal B. Jani, MBBS

Vishal B. Jani, MBBS

Vishal B. Jani, MBBS

Assistant Professor
School of Medicine, Omaha Campus

Academic Appointments

Department

  • Neurology

Position

  • Assistant Professor

Biography

Dr. Vishal Jani is an Assistant Professor in Department of Neurology at Creighton University School of Medicine.
 
Dr. Vishal Jani graduated from one of the largest medical school in Asia, B. J. Medical College, and pursued his postgraduate training at Michigan State University Lansing as a neurology resident where he also served as a chief resident in the Department of Neurology.  His sustained research interest in endovascular treatment of neurological diseases allowed him to subsequently finish a Vascular Neurology and NeuroInterventional Surgery Fellowship under the mentorship of eminent national leaders in the Division of Neurosurgery at Michigan State University.
 
Dr. Vishal Jani received several awards and honors as an active junior faculty committee member in Society of Vascular and Interventional Neurology and Society of NeuroInterventional Surgery and many other national and international professional organizations.  He is actively involved in research as well published in peer-reviewed journals.  His current area of research interest includes endovascular stroke and cerebral aneurysm treatment and strategic planning for optimizing delivery of state of the art care.

At present Dr Jani serves as System Stroke and Neuro-Intervention Medical Director for CHI health hospitals for the state of Nebraska and practices as consultat NeuroInterventionist at CHI health Immanuel Medical Center.

Publications and Presentations

Books

  • , 2(1), 95-98

Articles

  • , 13, https://www.cureus.com/articles/54685-risk-factors-and-incidence-of-acute-ischemic-stroke-a-comparative-study-between-young-adults-and-older-adults
  • , 96, https://n.neurology.org/content/96/15_Supplement/5127.abstract
  • , 16, 172-183
  • , 268, 240-247
  • , 31, 171-179
  • , 198, 106146
  • , 29
  • , 88, S136-S137
  • , 11(3), https://cdn.website-editor.net/169263edf0504b268a2a9c7ac1325d52/files/uploaded/jvin-11-3-6.pdf
  • , [Epub ahead of print], [Epub ahead of print]
  • , [Epub ahead of print], [Epub ahead of print]
  • , 25, 39-48
  • , 16(2), 191-201
  • , 1747493020904915
  • , 11 (4)
  • , 541-551
  • , 49(S1)
  • , 9(6)
  • , 13(1), 150-156
  • , 6(2), 51-8
  • , 6(2), 51-58
  • , 6(1), 7-10
  • , 22(4), 545-549
  • , 2011, 518621

Publications

  • , 11(4S)

Presentations

Awards and Honors

  • I have been a new consultant for product Brillinta. In May 2020, the US FDA approved a new indication for Brilinta to include the reduction of the risk of a first heart attack or stroke in high-risk patients with coronary artery disease. Thus i have helped company to provide path to educate physician for this specific indiaction being consultant., 2021
  • I have done consultation for delivery of care for secondary stroke prevention perticularly the recent emergenging data on PFO closure in cryptogenic stroke., 2019